Nutrien (NTR)

• Market cap: $23.9B
• 1 day: 1.38%
• 5 days: 4.80%
• 1 month: -4.63%
• 3 months: 4.29%
• 6 months: -16.02%
• Year to date: -15.08%
• 1 year: -10.76%
• 5 years: 4.74%
• 10 years: -11.54%

About: Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Employees: 25,900

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.79% less ownership

Funds ownership: 65.95% [Q2] → 65.17% (-0.79%) [Q3]

7% less repeat investments, than reductions

Existing positions increased: 202 | Existing positions reduced: 218

6% less funds holding

Funds holding: 618 [Q2] → 580 (-38) [Q3]

7% less capital invested

Capital invested by funds: $16.7B [Q2] → $15.5B (-$1.16B) [Q3]

33% less funds holding in top 10

Funds holding in top 10: 15 [Q2] → 10 (-5) [Q3]

38% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 101

43% less call options, than puts

Call options by funds: $225M | Put options by funds: $392M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $50 3% upside
• Avg. target: $54 10% upside
• High target: $60 24% upside

4 analyst ratings

• positive: 1 25%
• neutral: 3 75%
• negative: 0 0%

UBS Joshua Spector 60% 1-year accuracy 18 / 30 met price target	5% upside $51	Neutral Downgraded	10 Oct 2024
Wells Fargo Richard Garchitorena 57% 1-year accuracy 4 / 7 met price target	3% upside $50	Equal-Weight Downgraded	24 Sept 2024
RBC Capital Andrew Wong 73% 1-year accuracy 8 / 11 met price target	24% upside $60	Outperform Reiterated	20 Sept 2024
Goldman Sachs Adam Samuelson 36% 1-year accuracy 4 / 11 met price target	9% upside $53	Neutral Downgraded	10 Sept 2024